CME Group Inc. (NASDAQ:CME) Shares Bought by RWA Wealth Partners LLC

RWA Wealth Partners LLC lifted its position in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 106.9% during the 4th quarter, HoldingsChannel.com reports. The fund owned 3,050 shares of the financial services provider’s stock after acquiring an additional 1,576 shares during the quarter. RWA Wealth Partners LLC’s holdings in CME Group were worth $708,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in the company. SJS Investment Consulting Inc. increased its holdings in shares of CME Group by 570.6% in the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 97 shares during the period. Dunhill Financial LLC increased its stake in shares of CME Group by 188.4% in the third quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 81 shares during the period. New Age Alpha Advisors LLC increased its stake in shares of CME Group by 50.0% in the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock valued at $30,000 after purchasing an additional 43 shares during the period. Financial Life Planners bought a new stake in shares of CME Group during the fourth quarter valued at approximately $32,000. Finally, Knuff & Co LLC acquired a new position in shares of CME Group during the fourth quarter worth approximately $33,000. 87.75% of the stock is owned by institutional investors and hedge funds.

CME Group Trading Up 1.2 %

CME Group stock opened at $265.29 on Tuesday. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $267.91. The firm’s 50 day moving average price is $250.30 and its two-hundred day moving average price is $236.21. The firm has a market cap of $95.60 billion, a price-to-earnings ratio of 27.43, a price-to-earnings-growth ratio of 6.76 and a beta of 0.53. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01.

CME Group (NASDAQ:CMEGet Free Report) last issued its earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. On average, research analysts predict that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Friday, March 7th were paid a dividend of $1.25 per share. The ex-dividend date of this dividend was Friday, March 7th. This is a positive change from CME Group’s previous quarterly dividend of $1.15. This represents a $5.00 dividend on an annualized basis and a yield of 1.88%. CME Group’s dividend payout ratio is currently 51.71%.

CME Group announced that its board has approved a stock repurchase program on Thursday, December 5th that authorizes the company to buyback $3.00 billion in shares. This buyback authorization authorizes the financial services provider to repurchase up to 3.4% of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s board believes its stock is undervalued.

Wall Street Analysts Forecast Growth

CME has been the topic of several analyst reports. Royal Bank of Canada raised their target price on CME Group from $235.00 to $269.00 and gave the company a “sector perform” rating in a research report on Thursday, February 13th. Morgan Stanley raised their price target on CME Group from $256.00 to $263.00 and gave the company an “equal weight” rating in a report on Wednesday, February 19th. Keefe, Bruyette & Woods upped their price objective on shares of CME Group from $256.00 to $257.00 and gave the stock a “market perform” rating in a report on Friday, February 14th. Piper Sandler raised their target price on shares of CME Group from $250.00 to $258.00 and gave the company an “overweight” rating in a research note on Tuesday, January 7th. Finally, Citigroup lowered shares of CME Group from a “buy” rating to a “neutral” rating and reduced their price target for the stock from $255.00 to $250.00 in a research note on Monday, January 6th. Four equities research analysts have rated the stock with a sell rating, eight have issued a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $238.93.

Get Our Latest Stock Analysis on CME Group

Insiders Place Their Bets

In related news, insider Hilda Harris Piell sold 3,984 shares of the company’s stock in a transaction on Thursday, February 27th. The stock was sold at an average price of $250.47, for a total transaction of $997,872.48. Following the transaction, the insider now directly owns 27,046 shares of the company’s stock, valued at approximately $6,774,211.62. The trade was a 12.84 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Julie Winkler sold 11,592 shares of the firm’s stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $249.17, for a total value of $2,888,378.64. Following the sale, the insider now owns 21,885 shares of the company’s stock, valued at $5,453,085.45. The trade was a 34.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 27,076 shares of company stock worth $6,871,496 over the last ninety days. 0.30% of the stock is currently owned by company insiders.

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

See Also

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.